# Comparison of clinical efficacy, immune response and postoperative adverse reactions of transurethral holmium laser lithotripsy and percutaneous nephrolithotomy in elderly patients with complex upper urinary tract renal calculi: a retrospective cohort study

**Authors:** Dian Fu, Rui Chen, Xiaoming Yi, Ding Wu, Haowei He, Ping Li, Wenquan Zhou, Jingping Ge, Wen Cheng

PMC · DOI: 10.3389/fsurg.2025.1588563 · Frontiers in Surgery · 2025-10-29

## TL;DR

This study compares two kidney stone removal methods in elderly patients, finding that laser lithotripsy clears stones better and causes less kidney damage, though it takes longer.

## Contribution

The study provides new evidence comparing RIRS and PCNL in elderly patients with complex kidney stones, focusing on clinical outcomes and immune responses.

## Key findings

- RIRS showed higher stone clearance rates (86.84% and 76.32%) compared to PCNL (65.64% and 53.13%).
- RIRS caused less renal damage, as indicated by lower Scr, Cys-C, and KIM-1 levels post-surgery.
- Both procedures had similar adverse reaction rates but RIRS had shorter hospital stays and less bleeding.

## Abstract

This study aimed to evaluate the clinical efficacy, immune response, and postoperative adverse effects of transurethral holmium laser lithotripsy (RIRS) vs. percutaneous nephrolithotomy (PCNL) in elderly patients with complex upper urinary tract renal calculi.

A retrospective analysis was conducted on 70 elderly patients treated from January 2020 to January 2021. The control group (n = 32) underwent PCNL, while the observation group (n = 38) received transurethral holmium laser lithotripsy. Pre- and post-operative comparisons included serum creatinine (Scr), cystatin-C, kidney injury molecule-1 (KIM-1), immune indices, thyroxine (TH), and urokinase (UK). Stone clearance rates and adverse reactions were also assessed.

The observation group showed less bleeding, shorter hospital stays, higher hemoglobin decrease, and longer operation time (P < 0.05). Higher stone clearance rates were observed in the RIRS group at 86.84% and 76.32% for first and second stages, compared to 65.64% and 53.13% in the PCNL group. Postoperatively, Scr, Cys-C, and KIM-1 levels were lower in the RIRS group. Both groups exhibited decreased CD4+ and CD4+/CD8+, increased CD8+, reduced TH, and elevated UK levels post-surgery (P < 0.05). Adverse reactions were similar between groups.

For elderly patients with complex renal calculi, transurethral holmium laser lithotripsy offers superior stone clearance and reduced renal damage compared to PCNL, despite a longer operation time. Consideration of individual patient conditions is crucial for selecting the optimal procedure.

## Linked entities

- **Proteins:** HAVCR1 (hepatitis A virus cellular receptor 1)
- **Chemicals:** thyroxine (PubChem CID 853)
- **Diseases:** renal calculi (MONDO:0008171)

## Full-text entities

- **Genes:** HAVCR1 (hepatitis A virus cellular receptor 1) [NCBI Gene 26762] {aka CD365, HAVCR, HAVCR-1, KIM-1, KIM1, TIM}, CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** Stone (MESH:D007669), renal damage (MESH:D007674), urinary tract renal calculi (MESH:C563661), bleeding (MESH:D006470)
- **Chemicals:** Cys-C (-), TH (MESH:D013974), holmium (MESH:D006695), creatinine (MESH:D003404)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12605300/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12605300/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12605300/full.md

---
Source: https://tomesphere.com/paper/PMC12605300